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A Synthetic Superoxide Dismutase/Catalase Mimetic
EUK-207 Mitigates Radiation Dermatitis and Promotes
Wound Healing in Irradiated Rat Skin
Susan R. Doctrow1,4, Argelia Lopez2,4, Ashley M. Schock2, Nathan E. Duncan2, Megan M. Jourdan2,
Edit B. Olasz2, John E. Moulder3, Brian L. Fish3, Marylou Ma¨der3, Jozef Lazar2 and Zelmira Lazarova2
In the event of a radionuclear attack or nuclear accident, the skin would be the first barrier exposed to radiation,
though skin injury can progress over days to years following exposure. Chronic oxidative stress has been
implicated as being a potential contributor to the progression of delayed radiation–induced injury to skin and
other organs. To examine the causative role of oxidative stress in delayed radiation–induced skin injury, including
impaired wound healing, we tested a synthetic superoxide dismutase (SOD)/catalase mimetic, EUK-207, in a rat
model of combined skin irradiation and wound injury. Administered systemically, beginning 48hours after
irradiation, EUK-207 mitigated radiation dermatitis, suppressed indicators of tissue oxidative stress, and enhanced
wound healing. Evaluation of gene expression in irradiated skin at 30 days after exposure revealed a significant
upregulation of several key genes involved in detoxication of reactive oxygen and nitrogen species. This gene
expression pattern was primarily reversed by EUK-207 therapy. These results demonstrate that oxidative stress has
a critical role in the progression of radiation-induced skin injury, and that the injury can be mitigated by
appropriate antioxidant compounds administered 48hours after exposure.
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INTRODUCTION
Cutaneous radiation syndrome may occur after total or partial
body exposure to g-radiation, which penetrates deep into
underlying tissue. It can also result from exposure to high-
energy b-radiation that usually does not penetrate sufficiently
deep to cause hematopoietic, gastrointestinal, or neurovascu-
lar injury. Cutaneous radiation syndrome is an important
concern for subjects exposed during a radiological accident
or terrorist attack (Peter, 2005). Experience following the
Chernobyl nuclear plant accident showed the impact of skin
injury on patient prognosis. Almost half of the exposed
individuals suffered from cutaneous radiation syndrome and
nearly 50% of them died with primary cause of death attri-
buted to cutaneous radiation syndrome (Mettler et al., 2007).
Moreover, radiation dermatitis is a common consequence
of radiation cancer therapy and can be followed months
later with atrophy, fibrosis, or telangiectasia (Ryan, 2012).
It is well documented that cutaneous radiation exposure
impairs wound healing (Schwentker et al., 1998; Liu et al.,
2005; Riedel et al., 2005; Wang et al., 2006; Jourdan
et al., 2011).
Growing evidence links oxidative stress to skin injury
following acute radiation exposure (Robbins and Zhao, 2004;
Zhao et al., 2007). We addressed the hypothesis that an
antioxidant compound with appropriate properties would
show benefits in both acute and chronic models of cutaneous
radiation injury. We employed EUK-207, one of a class of
synthetic compounds, salen Mn complexes, which mimic the
antioxidant enzymes superoxide dismutase (SOD) and catalase,
scavenging the reactive oxygen species (ROS) superoxide, O2 ,
and hydrogen peroxide, H2O2 (Doctrow et al., 2002, 2005),
and reactive nitrogen species (Sharpe et al., 2002). Consistent
with their catalase activity, salen Mn complexes are peroxidase
mimetics (Doctrow et al., 2002), further broadening their
potential to scavenge hydroperoxides and otherwise modulate
the cellular redox environment. Such properties confer
advantages over other antioxidants, such as noncatalytic or
protein-based agents (Doctrow et al., 1997, 2003).
Prototype salen Mn complexes EUK-8, EUK-134, and EUK-
189 are cytoprotective in various experimental systems
(Doctrow et al., 2002, 2005; Halliwell and Gutteridge,
2007). EUK-207 is a newer-generation cyclized salen Mn
complex that has catalytic properties equivalent to those
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of EUK-134 and EUK-189, but greater stability and in vivo
half-life (Liu et al., 2003; Doctrow et al., 2005; Rosenthal
et al., 2011). The structure of EUK-207, with Mn bound to a
polyether cyclized salen ligand, has been previously reported
(Liu et al., 2003; Rosenthal et al., 2009). EUK-207 mitigates
delayed radiation injury to the lung (Mahmood et al., 2011;
Rosenthal et al., 2011) and kidney (Rosenthal et al., 2011) in
rats, protects murine hearts from cardiac ischemia–reperfusion
(Liesa et al., 2011), and improves age-associated cognitive
impairment in mice (Liu et al., 2003; Clausen et al., 2010). In
many of these efficacy models, salen Mn complexes are not
only functionally protective, but also suppress oxidative
modifications of proteins, lipids, and nucleic acids
(Gonzalez et al., 1995; Rong et al., 1999; Jung et al., 2001;
Liu et al., 2003; Zhang et al., 2004; Clausen et al., 2010;
Liesa et al., 2011; Mahmood et al., 2011). Salen Mn
complexes are of further interest, as compared with other
synthetic antioxidants, because of their ‘‘mito-protective’’
properties in experimental models of mitochondrial injury
(Melov et al., 2001; Doctrow et al., 2005; Liesa et al., 2011;
Rosenthal et al., 2011).
We developed an animal model of combined radiation and
wound injury to the skin where radiation-induced skin injury
affected B10% of total body surface, radiation did not
penetrate deep into the tissues, and radiation exposure was
accompanied by two full-thickness skin wounds (Jourdan
et al., 2011). Rats treated under this combined injury
protocol developed, in a radiation dose-dependent manner,
acute radiation dermatitis spanning in severity from
transient erythema to nonhealing ulcers, as well as markedly
impaired wound healing. Using this model, EUK-207 was
tested as a potential mitigating drug on end points relevant
to radiation dermatitis, skin wound healing, and chronic
oxidative stress.
RESULTS
EUK-207 mitigates radiation dermatitis
For this study, we used a 30 Gy radiation dose that, without
drug treatment, induced severe radiation dermatitis within
17–21 days after irradiation and ulcers that failed to heal
over the 90-day observation period (Jourdan et al., 2011).
Unanesthetized rats (n¼ 48) were randomly divided into two
experimental groups, irradiated, and given full-thickness
wounds as described in Materials and Methods. Control
animals (n¼ 14) were sham-irradiated and wounded in the
same manner. EUK-207 (1.8 mg kg1 per day) or vehicle
(water) was given by subcutaneous infusion beginning
48 hours after irradiation and continuing for up to 90 days.
This delayed time was selected because, in a mass casualty
scenario, therapies might be unavailable until long after
radiation exposure. Radiation dermatitis was scored weekly
as described in Materials and Methods.
The EUK-207-treated group showed reduced radiation
dermatitis severity by 30 days after irradiation (Figure 1a and
b). Skin injury scores continued to improve, remaining
significantly lower than in vehicle-treated rats (Po0.01;
Figure 1b). At 90 days after irradiation, EUK-207-treated rats
had only mild alopecia with multiple hairs growing in the
center of the radiation field. In contrast, vehicle-treated rats
had permanent alopecia, persistent erythema, and nonhealing
ulcers (Figure 1b).
EUK-207 improves wound healing and histological structure of
irradiated skin
At 21 days after wounding, EUK-207-treated rats showed
significantly smaller wounds than vehicle-treated rats (32%
vs. 58% of original wound size; Po0.05; Figure 2a). Wounds
in the EUK-207-treated group became completely healed
within 35±4 days (data not shown). This is in contrast to
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Figure 1. Mitigation of radiation dermatitis by EUK-207. (a) Macroscopic comparison of radiation dermatitis in representative rats with or without EUK-207
treatment at indicated radiation dose and time points. (b) Time course of skin injury scores; each point represents data from eight animals. The bars show the
median values and the error bars are the ranges. All scores beyond 21 days (*) are significantly reduced versus age-matched vehicle-treated animals (Po0.01).
Severe radiation dermatitis persists in the vehicle-treated rats at 90 days and the puncture wounds are not healed. Dermatitis is still evident in EUK-207-treated rats
at 30 days but puncture wounds were partially to fully closed by that time point, with complete wound healing, indicated by smooth circular scar, in the group by
day 40 (35±4 days).
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the wounds in the vehicle-treated group that, like those in the
originally described model (Jourdan et al., 2011), did not fully
heal during the duration of the study.
As new blood vessels are an integral part of granulation tissue
needed for the wound healing process, we evaluated blood
vessel density as described in Materials and Methods. The
number of blood vessels per optical field was decreased in
irradiated skin, as early as 7 days following irradiation, as
compared with nonirradiated control animals (9.8±2.9 vs.
25.3±4.6; Po0.0001). The lower blood vessel density
remained at the 14-day time point (9.4±3.7) and was further
declined (3.3±2.3) at 30 days after irradiation. The blood
vessel density in tissue samples taken from the wound edge 30
days after irradiation was markedly increased with EUK-207
treatment (29.8±14.3 vs. 3.3±2.3; Po0.006; Figure 2b and c).
On the basis of several histological indicators, the skin in
the EUK-207-treated group displayed reduced injury and a
more normalized phenotype (Figure 3a). These included
reduction of dermal thickness at 30 and 90 days (Po0.005),
increased epidermal thickness at 30 days (Po0.005), and
restoration of hair growth signified by the increased number of
hair follicles (Po0.03; Figure 3b).
EUK-207 normalizes the gene expression pattern in irradiated skin
Chronic oxidative stress has been implicated in the progres-
sion of radiation-induced late effects, potentially through the
activation or repression of genes in important signaling path-
ways, but the specific genes involved in radiation-induced
skin injury are ill defined. Therefore, we obtained gene
expression data on skin samples taken 30 days after irradia-
tion. To evaluate gene expression patterns relevant to oxida-
tive stress, mRNA was prepared from unirradiated and
irradiated (control and EUK-207-treated) rats and analyzed
by microarray as described in Materials and Methods. The
data indicated that irradiation caused upregulation of 15
genes, including those involved in generation or detoxification
of ROS, and downregulation of genes involved in excisional
DNA repair (Xpa) or innate immunity (Mpo) (Table 1a). These
changes were abrogated in skin from irradiated rats receiving
EUK-207. In these rats, there was upregulation of only three
genes from the oxidative stress pathway, all changes distinct
from those in the vehicle-treated group (Table 1b).
EUK-207 reduces oxidation of proteins and nucleic acids
As the gene expression data demonstrated radiation-induced
dysregulation of genes responsive to oxidative stress, we
examined oxidative modifications of proteins and nucleic
acids to confirm the occurrence of chronic oxidative stress
in irradiated skin. Protein carbonylation is a commonly used
biomarker of irreversible oxidative damage to proteins (Levine,
2002). Skin extracts from the irradiated rats showed increased
protein carbonyls at 30 and 90 days after irradiation, with one
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Figure 2. Wound closure and evaluation of blood vessels in irradiated skin. (a) The columns represent mean values, bars±SD, and the asterisk denotes
significantly greater wound closure in EUK-207-treated versus vehicle-treated irradiated animals. Each time point represents data from seven animals.
(b) Representative fluorescence micrograph demonstrating a number of CD31-positive vessels in skin samples taken from the wound edge at the 30-day
postirradiation time point. (c) The quantification of CD31-positive vessels in irradiated and EUK-207- or vehicle-treated wound edge skin. *Po0.006.
Bar¼100mm.
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prominent band (molecular weight B68 Kd) likely corres-
ponding to albumin, which, because of abundance, frequently
appears as a major carbonylated band (Levine et al., 1994).
The cumulative density of all carbonylated bands was
significantly attenuated by EUK-207 treatment (Po0.05;
Figure 4a and b). Along with chronic oxidative damage to
proteins, skin from irradiated rats also exhibited evidence for
nucleic acid injury. Staining for oxidized 8-hydroxyguanosine,
a marker for DNA oxidation, was evident in irradiated skin
even at 90 days after irradiation, and substantially decreased
with EUK-207 treatment (Figure 4c and d).
DISCUSSION
It is well known that irradiation causes the immediate
generation of short-lived ROS, but the role of chronically
generated ROS in longer-term damage, although hypothesized
and increasingly implicated (Zhao et al., 2007; Zhao and
Robbins, 2009), is not well documented. Our study
demonstrates that chronic oxidative stress occurs in
irradiated skin, even a month or more after exposure.
Furthermore, the marked reduction of skin injury by a
synthetic SOD/catalase mimetic, EUK-207, concomitant with
its abrogation of oxidative stress indicators, demonstrates that
oxidative stress is causative in both chronic radiation
dermatitis and impaired wound healing in irradiated skin.
Because EUK-207 was initiated 48 hours after exposure, there
is no question that the ROS targeted in our study are those
generated well after the initial radiation insult.
Increased localized expression of known antioxidant pro-
teins was shown to decrease cutaneous radiation injury (Yan
et al., 2008; Zhang et al., 2012). We further demonstrate,
through mitigation by a synthetic antioxidant agent, that
oxidative stress causes both the dermatitis and wound
healing impairments characteristic of delayed radiation
injury. Possibly, previously tested antioxidants lacked the
appropriate ROS specificity, or did not have adequate bio-
availability to the skin, or both. The required bioavailability
may include access to the mitochondria, as mitochondrial
dysfunction has been implicated in cellular sensitivity to
radiation injury (Greenberger and Epperly, 2004; Jiang et al.,
2009; Aykin-Burns et al., 2011). Although we have not
directly tested the role of ‘‘mito-protection’’ in this study,
salen Mn complexes suppress oxidative mitochondrial injury
in other experimental models (Melov et al., 2001; Doctrow
et al., 2005; Liesa et al., 2011). Among the oxidative stress-
responsive genes we found to be upregulated in irradiated
vehicle-treated skin is Sod2, for the mitochondrial antioxidant
enzyme, manganese SOD (Table 1a). Sod2 is also upregulated
in other models for radiation exposure, and increased SOD
expression in the mitochondria is radioprotective (Wong et al.,
1996; Epperly et al., 2007; Greenberger and Epperly, 2007).
Our data also showed upregulation of genes for glutathione
peroxidase 1 (Gpx1) and peroxiredoxin 5 (Prdx5). Prdx5 has
been found in the mitochondria and is regarded as a
potentially important scavenger of mitochondrial ROS,
particularly hydroperoxides (Cox et al., 2010). Gpx1, a
cytosolic enzyme, has been reported to have a role in
modulating the mitochondria, through redox changes, and
its upregulation has been implicated in mitochondrial
dysfunction (Handy et al., 2009). Overall, an upregulation of
such mitochondrially associated antioxidant enzymes is
potentially indicative of oxidative mitochondrial injury. If so,
then prevention of their upregulation by EUK-207 (Table 1b) is
consistent with a hypothesis that the compound’s mitigating
effects on cutaneous radiation injury are, at least in part,
related to its ability to protect the mitochondria. However, its
suppression of nearly all the changes in oxidative stress-
responsive genes in irradiated skin indicates that EUK-207 is
not acting exclusively at the mitochondria. This agrees with
previous reports showing the suppression of both mitochon-
drial (Melov et al., 2001; Liu et al., 2003; Hinerfeld et al.,
2004; Liesa et al., 2011) and nonmitochondrial (Rong et al.,
1999; Zhang et al., 2004; Peng et al., 2005; Liesa et al., 2011)
oxidative modifications by salen Mn complexes. Indeed,
unlike MitoQ and certain other antioxidants (Murphy and
Smith, 2007; Demianenko et al., 2010), the salen Mn
complexes were not designed for specific mitochondrial
targeting. It is interesting to note that, in the irradiated rat
skin, the gene for Gpx2 was downregulated with vehicle, yet
upregulated with EUK-207 treatment. The significance of this
reversal in Gpx2 expression by EUK-207 is not yet apparent,
but should be studied further. Although there is little literature
to address its potential role in radiation injury or wound
healing, Gpx2 has been reported to have both a cytoplasmic
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Figure 3. Histological evaluation of irradiated skin. (a) Hematoxylin and eosin
staining of irradiated skin from rats with or without EUK-207 treatment at
indicated time points after irradiation. (b) Evaluation of epidermal and dermal
thickness (mm) and number of hair follicles in the skin of experimental and
control animals at 30 and 90 days after irradiation. *Po0.005, **Po0.03.
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and a mitochondrial location in yeast (Ukai et al., 2011). In a
recent study using diabetic mice (Tie et al., 2012), GI-PS, a
polysaccharide derived from the medicinal fungi Ganoderma
lucidum, accelerated wound healing while increasing total
Gpx activity in the skin. This enzymatic activity, of course,
likely represents a combination of Gpx1, Gpx2, and perhaps
other forms. The GI-PS also increased skin manganese SOD
activity, not by changing the protein’s expression but, instead,
by suppressing its nitration, a known mechanism of its
inactivation during oxidative stress. On the basis of the latter
finding, Tie et al. (2012) attributed the wound healing
properties of GI-PS to its known antioxidant properties and,
in particular, to an inhibition of mitochondrial oxidative stress.
In our study, it is also of interest that EUK-207 appeared to
upregulate expression of Prdx6. Studies with Prdx6 knockout
mice have indicated that Prdx6 is essential for blood vessel
integrity during skin wound healing, with vascular endothelial
cells appearing to be highly sensitive to the loss of this new
peroxiredoxin (Kumin et al., 2007). Thus, in our model, the
ability of EUK-207 to increase Prdx6 expression may relate to
the compound’s beneficial effects on wound healing and
angiogenesis. From our perspective, these changes in gene
expression are of interest as preliminary leads for future study,
including a more detailed analysis of whether EUK-207
modulates protein levels or enzymatic activities of any of
these potentially key antioxidant proteins during wound
healing in irradiated skin.
On the basis of its other reported in vivo effects in radiation
injury models (Mahmood et al., 2011; Rosenthal et al., 2011),
mitigation of radiation dermatitis severity by EUK-207 was not
unexpected. However, improved wound healing by a ROS
scavenger was not necessarily predicted from literature
describing a very complex association between ROS and
normal skin wound healing. ROS, particularly H2O2, are
believed to have key signaling roles to promote wound
healing, and localized transfection of catalase delays healing
in rodents (Roy et al., 2006; Sen and Roy, 2008). Yet, excess
H2O2 impairs (Roy et al., 2006) and transfection with Sod2
Table 1. Evaluation of oxidative stress–related gene expression in irradiated skin
UniGene ID Reference sequence Gene symbol Gene name Fold change
(a) Differentially expressed genes in irradiated and vehicle-treated skin
Rn.162331 XM_344156 Ncf2 Neutrophil cytosolic factor 2 70.07
Rn.3928 NM_144737 Fmo2 Flavin containing monooxygenase 2 29.61
Rn.38575 NM_053734 Ncf1 Neutrophil cytosolic factor 1 19.20
Rn.10488 NM_017051 Sod2 Superoxide dismutase 2, mitochondrial 17.54
Rn.32351 NM_138828 ApoE Apolipoprotein E 12.34
Rn.2710 NM_031140 Vim Vimentin 10.35
Rn.55542 NM_024141 Duox2 Dual oxidase 2 10.02
Rn.137930 XM_225268 RGD1560658 Similar to serine (or cysteine) proteinase inhibitor, clade B, member 1b 7.58
Rn.40511 NM_021588 Mb Myoglobin 6.23
Rn.27588 XM_236702 Xirp1 Xin actin-binding repeat containing 1 5.70
Rn.2944 NM_053610 Prdx5 Peroxiredoxin 5 4.50
Rn.11323 NM_030826 Gpx1 Glutathione peroxidase 1 4.42
Rn.19721 NM_053906 Gsr Glutathione reductase 3.61
Rn.105938 NM_130744 Cygb Cytoglobin 3.40
Rn.11234 NM_017000 Nqo1 NAD(P)H dehydrogenase, quinone 1 3.01
Rn.12469 XM_216403 Xpa Xeroderma pigmentosum, complementation group A -3.03
Rn.3503 NM_183403 Gpx2 Glutathione peroxidase 2  3.80
Rn.25565 XM_214130 Zmynd17 Zinc finger, MYND-type containing 17  3.81
Rn.47782 XM_220830 Mpo Myeloperoxidase  4.17
Rn.1023 NM_139192 Scd1 Stearoyl-Coenzyme A desaturase 1  5.18
Rn.9470 XM_216452 Dhcr24 24-dehydrocholesterol reductase  14.96
(b) Differentially expressed genes in irradiated and EUK-207-treated skin
Rn.42 NM_053576 Prdx6 Peroxiredoxin 6 3.21
Rn.107334 NM_013096 Hba-a2 Hemoglobin a, adult chain 2 3.31
Rn.3503 NM_183403 Gpx2 Glutathione peroxidase 2 3.50
The list of differentially expressed genes in irradiated skin at 30 days following irradiation, from rats treated with (a) vehicle or (b) EUK-207 as described in
Materials and Methods.
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improves wound healing (Luo et al., 2004), as does chronic
administration of a mitochondrially targeted antioxidant
(Demianenko et al., 2010). Our observation that EUK-207
treatment resulted in increased angiogenesis in the irradiated
wounded skin is particularly intriguing. ROS are believed to
mediate mitogenesis stimulated by growth factors including
the angiogenic factor, vascular endothelial growth factor
(Ushio-Fukai and Alexander, 2004; Roy et al., 2006).
Interestingly, an endogenously generated oxidized lipid
product promotes angiogenesis and wound healing in a
vascular endothelial growth factor–independent manner
(West et al., 2010). Thus, one might expect an antioxidant
to impair rather than, as we observe, facilitate angiogenesis.
It is conceivable that in our combined injury model, by
promoting a more normalized skin phenotype (e.g., Figures
1 and 3), EUK-207 is inducing a microenvironment that
facilitates more normal wound healing, enabling tissue
remodeling processes, including new blood vessel growth
(Gurtner et al., 2008). In support of this, the basement
membrane deposition of laminin 332 is impaired in our
model (Jourdan et al., 2011) and is improved with EUK-207
treatment (data not shown). More broadly, EUK-207 may
modify the microenvironment through suppression of
oxidation-dependent events that might otherwise destroy
microvasculature in irradiated tissue. Consistent with this,
EUK-207 treatment preserves the microvasculature after lung
irradiation. Thus, overall, the role of ROS, particularly H2O2,
and of redox regulation in cutaneous wound healing and its
associated angiogenesis is highly complex. Despite this
complexity, our study supports the concept that selected
ROS-scavenging agents such as EUK-207, having the appro-
priate specificity and given under the right circumstances, can
mitigate radiation-induced skin injury, including facilitating
wound healing.
MATERIALS AND METHODS
Animals
A total of 62 syngeneic male WAG/RijCmcr 8-week-old rats bred and
housed in a moderate security barrier were used for this study. Rats
were monitored daily and maintained on a 12-hour light/dark cycle,
with free food and water intake. At the times specified below, animals
were killed using isoflurane inhalation. All animal research was
approved by the Medical College of Wisconsin Institutional Animal
Care and Use Committee.
Irradiation and wounding protocol
We used our previously published protocol (Jourdan et al., 2011).
Unanesthetized rats were immobilized and irradiated with an X-ray
beam with a steep dose gradient in the dorsoventral direction (without
injury to the internal organs). The source-to-skin distance was 37 mm
and the dose rate was 0.68 Gy per minute. The irradiated area of skin
corresponded to 10% of the total body surface. Animals were
randomly divided into two experimental groups and either sham-
irradiated (n¼ 14) or irradiated with a single dose of 30 Gy defined at
the dermal layer (n¼ 48). Within 1 hour after irradiation, all rats were
anesthetized, and two full-thickness wounds were made on the back
of each rat within the irradiation field using an 8-mm punch biopsy.
The wounds were left uncovered and animals were housed
individually to prevent damage to the wound site.
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Figure 4. Detection of oxidative stress markers in irradiated skin. (a) Representative western blot of carbonylated proteins at different time points.
(b) Densitometric evaluation of carbonylated proteins. *Statistically significant differences (vs. 30 Gy; Po0.05). All experimental conditions were run in triplicate.
(c) Immunohistochemical staining was used to locate the DNA oxidation product 8-hydroxyguanosine (8-OHdG) in irradiated and EUK-207- or vehicle-treated
skin, 90 days after irradiation. (d) The intensity of 8-OHdG staining was quantified in the skin, as described in Materials and Methods. *Statistically significant
decreased staining in EUK-207-treated irradiated animals (Po0.001 vs. vehicle-treated irradiated animals). Bar¼ 200mm.
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Implantation of osmotic pumps for drug delivery
The custom-synthesized EUK-207 (Liesa et al., 2011) was dissolved in
ultrapure water, filter-sterilized, and administered by subcutaneous
Alzet infusion pumps (DURECT, Cupertino, CA) at 1.8 mg kg 1 per
day beginning 48 hours after irradiation and continuing for up to 90
days. Sham-irradiated or irradiated-only animals received pumps
filled with vehicle. The EUK-207 dose was B4-fold lower than
doses used previously to mitigate radiation injury to rat lung
(Mahmood et al., 2011) and kidney (Rosenthal et al., 2011). This
lower dose was selected to eliminate the localized skin toxicities
observed in those prior studies, while remaining well within the
effective EUK-207 dose range reported in other rodent models (see,
e.g., Liu et al., 2003).
Monitoring of radiation dermatitis and wound closure
Photographs of animals were taken three times per week and coded.
The skin injury score was assessed from coded images by two
investigators in a masked manner according to a previously published
scoring system (Jourdan et al., 2011). Wound contraction was
assessed at days 0, 3, 7, 14, and 21. Wound areas were not
calculated at later time points because of heavy crusts covering the
wounds and multiple erosions blending into the wound site. Wound
area was determined as described (Jourdan et al., 2011) and wound
contraction was calculated as follows:
Percentage wound contraction on Nth day¼
100 wound area on N
th day
wound area on 1st day
 !
100
Skin histological analysis
Skin samples from four animals per experimental group (group 1:
irradiated and vehicle-treated; group 2: irradiated and EUK-207-
treated) were harvested at 30 and 90 days after irradiation, fixed in
4% formaldehyde, and embedded in paraffin. Tissue sections were
stained with hematoxylin and eosin. Epidermal thickness was deter-
mined by measuring the epidermal layer and dermal thickness was
determined by measuring the dermis from dermoepidermal junction
to the top of fatty layer three times in three consecutive optical fields
in each skin sample using Scion image analysis software (National
Institutes of Health, Bethesda, MD). The number of hair follicles was
determined by manually counting the hair follicles in three con-
secutive optical fields.
Total RNA extraction and reverse transcription
Skin samples from five animals per experimental group (group 1:
irradiated and vehicle-treated; group 2: irradiated and EUK-207-
treated; group 3: sham-irradiated and vehicle-treated) were harvested
at 30 days after irradiation. Samples were washed in ice-cold
phosphate-buffered saline (Life Technologies, Carlsbad, CA) and
immediately immersed in RNA Later (Life Technologies). The total
RNA was prepared using RNeasy Fibrous tissue Mini Kit (Life
Technologies), the RNA concentration was determined by
260:280 nm absorbance ratios, equal amounts of RNA from each
sample in the experimental group were pooled, and complementary
DNA was synthesized from 1mg of total RNA.
Microarray analysis of skin samples
To determine the relative expression of genes associated with
oxidative stress, quantitative real-time reverse transcriptase–PCR
analysis was performed with RT2 first-strand complementary DNA
kit (SABiosciences, Frederick, MD) and Rat Oxidative Stress and
Antioxidant Defense RT2 Profiler PCR Array (SABiosciences). The
samples were diluted in qPCR master mix and pipetted into 96-well
array plates to evaluate the expression of 84 oxidative stress–related
genes. Quantitative–PCR was performed in technical duplicates using
Applied Biosystems Step One Plus Real-Time PCR Systems (Applied
Biosystems, Carlsbad, CA). Quality controls included in each plate
confirmed the lack of DNA contamination and tested for successful
PCR performance. For data analysis of PCR, the DDCt method was
used with algorithms provided by the manufacturer. Fold changes
were then calculated and expressed as log-normalized ratios of
values from irradiated and sham-irradiated tissues or irradiated and
EUK-207-treated tissues.
Detection of carbonylated proteins in the skin extracts
To detect the carbonyl groups we used the Oxyblot Oxidized Protein
Detection Kit (Chemicon International, Temecula, CA), which detects
proteins containing 2,4-dinitrophenol–derivatized carbonyl groups by
immunoblotting. Skin tissue samples were rapidly frozen in liquid
nitrogen. Equal amounts (100 mg) of skin tissue were each homo-
genized in ice cold 20 mM Tris HCl buffer containing Protease
Inhibitor Cocktail (Sigma-Aldrich, St Louis, MO), incubated
for 30 minutes on ice, and then centrifuged at 10,000 r.p.m. for
20 minutes at 4 1C. The supernatant was collected and protein
concentration was determined by the Bio-Rad Protein Assay (Bio-
Rad Laboratories, Hercules, CA). The 20mg aliquots of protein
extracts were analyzed according to the manufacturer’s protocol.
Following the Oxyblot procedure, the polyvinylidene difluoride
membrane was stripped and probed with specific anti-b-actin anti-
bodies (Santa Cruz Biotechnology, Santa Cruz, CA). The protein
bands on the membrane were detected using a chemiluminescence
detection kit (Pierce, Rockford, IL). The intensity of the bands was
quantified by densitometric analysis with ImageJ 1.43 (NIH, Bethesda,
MD) and expressed as density relative to b-actin loading control.
Detection of DNA oxidation products
To further confirm the occurrence of oxidative stress in the irradiated
skin at 90 days after irradiation, we evaluated DNA oxidation using
immunohistochemistry. The paraffin-embedded skin sections were
deparaffinated, rehydrated, and treated with sodium citrate buffer
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0) for 10 minutes at
95 1C. After washing, samples were incubated with mouse anti-8-
hydroxyguanosine IgG (Abcam, Cambridge, MA) overnight at 4 1C
after biotinylation and a blocking procedure, which followed the
manufacturer’s protocol (Vector Laboratories, Burlingame, CA). Mouse
IgG2a (Abcam) served as an isotype control. After development with
diaminobenzidine, the sections were counterstained with hematox-
ylin, coded, and evaluated under a light microscope. Five consecutive
images from each slide and the pixels corresponding to the stained
region were measured using the ImageJ program 1.43 (NIH).
Blood vessel density
The skin and wound edge samples were embedded in optimal cutting
temperature compound (Sakura, Japan) for immunofluorescence
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studies. Skin sections (6mm) were incubated with anti-CD31 IgG (BD
Biosciences, San Jose, CA) overnight at 4 1C. The mouse IgG2a
(Abcam) served as a negative control. The blood vessels were
detected by FITC-conjugated goat F (ab0)2 anti-mouse IgG (Santa
Cruz Biotechnology). The slides were coded and evaluated under a
fluorescent microscope. Blood vessels in five consecutive images
from each slide were counted from four animals per experimental
group.
Statistical analysis
For radiation dermatitis scores, differences in treatment group
medians were assessed using Wilcoxon–Mann–Whitney rank-sum
test. For histological analysis, all values were expressed as mean±SD
and differences assessed using two-tailed Student’s t-test. For all other
data, differences among treatment group means were assessed using a
one-way analysis of variance followed by Student–Newman–Keuls
post hoc test and data expressed as mean±SD. For all analyses,
Po0.05 was considered to be statistically significant.
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